Latest News

Quanta News

Quanta Successfully Completes Pilot Treatments in France

25th April 2018

Alcester, UK, 25 April 2018.  Seroba’s investee company Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a medical device company providing innovative haemodialysis solutions, has announced that it has successfully completed a clinical pilot to treat patients in France. Building […]

Read More
Medtech News

Major European Medtech Summit in Dublin

5th April 2018

April 2018.  Seroba Life Sciences is pleased to announce that it will sponsor a major European Medtech Summit in Dublin during April.  The conference, now in its 6th year, will be held at the Shelbourne Hotel from 17th to 19th […]

Read More
Prexton News

Prexton Acquired by Lundbeck for up to €905m

16th March 2018

Oss, The Netherlands & Dublin, Ireland, 16 March 2018 – H. Lundbeck A/S (Lundbeck) and Seroba’s Investee Company, Prexton Therapeutics BV (Prexton), today announced the signing of a definitive agreement in which Lundbeck will acquire Prexton. Under the terms of […]

Read More
Pq Bypass

Doctors Perform ‘Bypass’ Without Surgery

2nd March 2018

Seroba’s investee company, PQ Bypass was making eye-catching headlines in the USA this week.  Arkansas Heart Hospital is the first U.S. hospital to perform the DETOUR procedure and the story was carried on Little Rock’s news source, ArkansasMatters. You can […]

Read More
Pq Bypass

PQ Bypass Announces First Patient Treated in DETOUR II Trial

23rd February 2018

PQ Bypass Announces First Patient Treated in Landmark DETOUR II Trial Evaluating New Treatment Approach for Clogged Leg Arteries.  Pivotal Trial Now Underway in the United States for First-of-its-Kind Procedure in Patients with Severe Peripheral Artery Disease (PAD) SUNNYVALE, Calif. […]

Read More
Biomimics 3d

Veryan Announces Submission of its PMA Application to the FDA

31st January 2018

1 February 2018: Seroba’s investee company, Veryan Medical, has announced that the Company has submitted a Premarket Approval (PMA) application for the BioMimics 3D Vascular Stent System to the U.S. Food & Drug Administration. Pivotal to the content of the PMA […]

Read More
T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19

Scroll to Top